Expertise in
2
conditions

Emmanuelle K. Mercier

Tours, FR 
Expertise in
2
conditions
Tours, FR 
OverviewLocationsClinical Research

Overview

Emmanuelle Mercier practices in Tours, France. Ms. Mercier is highly rated in 2 conditions, according to our data. Her top areas of expertise are Pneumonia, Sepsis, Hospital-Acquired Pneumonia, and Acute Respiratory Distress Syndrome (ARDS).

Her clinical research consists of co-authoring 71 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Tours, France
Other Locations
Besancon, France
Lyon, 86000, France
Angers, France
Dijon, France
Nimes, France
Limoges, France
Poitiers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Innate Immunity During Community Acquired Pneumonia: A Translational Approach
Innate Immunity During Community Acquired Pneumonia: A Translational Approach
Enrollment Status: Terminated
Publish Date: November 24, 2025
Intervention Type: Other
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Drug: Dobutamine
Study Phase: Phase 3
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Enrollment Status: Completed
Publish Date: October 24, 2019
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
InterLeukine Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
InterLeukine Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
Enrollment Status: Completed
Publish Date: February 25, 2019
Intervention Type: Biological
Study Phase: Phase 3
View 7 Less Clinical Trials

71 Total Publications

Correction: Impact of non-invasive oxygen reserve index versus standard SpO2 monitoring on peripheral oxygen saturation during endotracheal intubation in the intensive care unit: Protocol for the randomized controlled trial NESOI2.
Correction: Impact of non-invasive oxygen reserve index versus standard SpO2 monitoring on peripheral oxygen saturation during endotracheal intubation in the intensive care unit: Protocol for the randomized controlled trial NESOI2.
Journal: PloS one
Published: July 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mercier's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile